HTGC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hercules Capital Inc (HTGC) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has demonstrated strong financial growth in the latest quarter and maintains a solid dividend, the stock faces headwinds from negative sentiment in the news, a bearish technical trend, and a lack of strong trading signals. Additionally, options data indicates bearish sentiment, and analysts have recently downgraded the stock, citing macro uncertainty and risks related to its software exposure. Given these factors, it is better to hold off on investing in HTGC for now.
The technical indicators show a bearish trend. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the RSI is neutral at 48.831. The MACD is slightly positive at 0.0154 but not strong enough to indicate a clear upward momentum. Key support and resistance levels suggest limited upside potential in the short term.
Hercules Capital has maintained a BBB (high) investment-grade credit rating, reflecting strong performance and adaptability.
The company was named the 2025 BDC Manager of the Year - Americas for its exceptional performance in financing amid challenging market conditions.
Strong financial performance in Q4 2025, with revenue up 38.24% YoY and net income up 48.33% YoY.
Investigations by Pomerantz LLP and Johnson Fistel, PLLP for potential securities fraud and federal law violations.
Concerns about software exposure (35%) and risks from AI disruption.
Negative sentiment in the market, with widespread discontent and concerns about a bleak future.
Analysts have downgraded the stock, citing macro uncertainty and limited near-term upside.
In Q4 2025, Hercules Capital reported strong financial growth: revenue increased by 38.24% YoY to $141.35M, net income rose by 48.33% YoY to $90.22M, EPS grew by 29.73% YoY to $0.48, and gross margin remained high at 97.98%.
Recent analyst ratings are mixed to slightly negative. Keefe Bruyette lowered the price target to $19 (from $20) but maintained an Outperform rating. Piper Sandler downgraded the stock to Neutral from Overweight, with a reduced price target of $17.50 (from $20.50), citing macro uncertainty and risks from software exposure. Lucid Capital initiated coverage with a Buy rating and a $19.75 price target, highlighting the company's strong track record and market position.
